CN Patent

CN103370101A — 用于治疗hiv相关性腹泻的方法和组合物

Assigned to Salix Pharmaceuticals Inc · Expires 2013-10-23 · 13y expired

What this patent protects

本文公开了通过以足以治疗腹泻的量向需要其的患者给药氯离子转运抑制剂来治疗腹泻的方法。腹泻的治疗包括腹泻和疼痛、腹部不适以及与腹泻相关的其它症状的治疗。在一个实施方案中，氯离子转运抑制剂是Crofelemer。

USPTO Abstract

本文公开了通过以足以治疗腹泻的量向需要其的患者给药氯离子转运抑制剂来治疗腹泻的方法。腹泻的治疗包括腹泻和疼痛、腹部不适以及与腹泻相关的其它症状的治疗。在一个实施方案中，氯离子转运抑制剂是Crofelemer。

Drugs covered by this patent

Patent Metadata

Patent number
CN103370101A
Jurisdiction
CN
Classification
—
Expires
2013-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Salix Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.